Isoray to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Rhea-AI Summary

Isoray, a medical technology company specializing in seed brachytherapy, announced that CEO Lori Woods will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 23 at 1:40 p.m. ET. Together with CFO Jonathan Hunt, they will conduct virtual meetings with institutional investors. A live webcast of the presentation will be available on Isoray's website and an on-demand replay will be offered for 90 days following the event.

Isoray is the sole producer of Cesium-131 brachytherapy seeds, enhancing treatment options for various conditions.

News Market Reaction – ISR

+5.69%

+5.69% Session move

In the trading session that priced this news, ISR gained 5.69%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

RICHLAND, Wash., Sept. 16, 2020 (GLOBE NEWSWIRE) --  Isoray, Inc. (NYSE American: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced that Chief Executive Officer Lori Woods will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on Wednesday, September 23 at 1:40 p.m. ET. CEO Woods and Chief Financial Officer Jonathan Hunt will also host virtual one-on-one and group meetings with institutional investors during the conference.

A live webcast of the presentation will be available on Isoray’s Investor Relations section of the Company’s website at https://isoray.com/investors/presentations/. An on-demand replay of the presentation will be available shortly after the conclusion of the presentation on the Investor Relations section of the website and will be available for 90 days.

About Isoray
Isoray, Inc., through its subsidiary, Isoray Medical, Inc. is the sole producer of Cesium-131 brachytherapy seeds, which are expanding brachytherapy options throughout the body. Learn more about this innovative Richland, Washington company and explore the many benefits and uses of Cesium-131 by visiting www.isoray.com. Follow us on LinkedIn and Twitter. Join us on Facebook.

Contact: 
Investor Relations: Mark Levin (501) 255-1910
Media and Public Relations: Sharon Schultz (302) 539-3747

FAQ

When will Isoray CEO Lori Woods present at the Oppenheimer Summit?

Lori Woods will present on September 23 at 1:40 p.m. ET at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit.

How can I watch the Isoray presentation at the Oppenheimer Summit?

The presentation will be available via a live webcast on Isoray's Investor Relations website.

What is the focus of Isoray's business?

Isoray specializes in seed brachytherapy, producing Cesium-131 seeds to expand treatment options for various medical conditions.

Will the Isoray presentation be available after the live event?

Yes, an on-demand replay of the presentation will be available for 90 days after the live event.

Who will join CEO Lori Woods during the Oppenheimer Summit?

CFO Jonathan Hunt will also participate in the conference, hosting virtual meetings with investors.